Ambit Biosciences Corp (AMBI) financial statements (2020 and earlier)

Company profile

Business Address 11080 ROSELLE STREET
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

6/30/2014
TTM
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 71
Cash and cash equivalents 71
Receivables 1
Other undisclosed current assets 1
Total current assets: 73
Noncurrent Assets
Property, plant and equipment 1
Restricted cash and investments 0
Total noncurrent assets: 1
TOTAL ASSETS: 74
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 10
Accounts payable 2
Accrued liabilities 1
Employee-related liabilities 2
Accounts payable and other accrued liabilities5
Other undisclosed current liabilities 7
Total current liabilities: 16
Noncurrent Liabilities
Total liabilities: 16
Stockholders' equity
Stockholders' equity attributable to parent 58
Common stock 0
Additional paid in capital 306
Accumulated other comprehensive loss (0)
Accumulated deficit (248)
Total stockholders' equity: 58
TOTAL LIABILITIES AND EQUITY: 74

Income statement (P&L) ($ in millions)

6/30/2014
TTM
12/31/2013
Operating expenses (34)
Other undisclosed operating income 27
Operating loss: (7)
Nonoperating expense (4)
Interest and debt expense (0)
Loss from continuing operations before equity method investments, income taxes: (12)
Other undisclosed income from continuing operations before income taxes 0
Loss from continuing operations before income taxes: (11)
Income tax benefit 0
Net loss: (11)
Net income attributable to noncontrolling interest 0
Net loss attributable to parent: (11)
Preferred stock dividends and other adjustments (4)
Other undisclosed net income available to common stockholders, basic 2
Net loss available to common stockholders, diluted: (13)

Comprehensive Income ($ in millions)

6/30/2014
TTM
12/31/2013
Net loss: (11)
Other undisclosed comprehensive loss (0)
Comprehensive loss, net of tax, attributable to parent: (12)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: